Published in J Virol on December 26, 2013
Poxvirus Protein MC132 from Molluscum Contagiosum Virus Inhibits NF-B Activation by Targeting p65 for Degradation. J Virol (2015) 0.78
Recent advances on viral manipulation of NF-κB signaling pathway. Curr Opin Virol (2015) 0.78
Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence. PLoS Pathog (2015) 0.77
Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators. Vaccine (2016) 0.75
Multiple Bcl-2 family immunomodulators from vaccinia virus regulate MAPK/AP-1 activation. J Gen Virol (2016) 0.75
Molluscum Contagiosum Virus Protein MC005 Inhibits NF-κB Activation by Targeting NEMO-Regulated IκB Kinase Activation. J Virol (2017) 0.75
A parapoxviral virion protein inhibits NF-κB signaling early in infection. PLoS Pathog (2017) 0.75
Pathogen recognition and innate immunity. Cell (2006) 44.14
Shared principles in NF-kappaB signaling. Cell (2008) 20.96
Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol (2009) 11.76
Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J Virol (1988) 4.92
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A (2000) 3.69
A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell (1992) 3.36
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology (1994) 2.89
The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med (2003) 2.85
Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med (2005) 2.66
Poxvirus genomes: a phylogenetic analysis. J Gen Virol (2004) 2.40
Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem (2004) 2.21
Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell (1992) 2.19
The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J Virol (2004) 2.10
Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc Natl Acad Sci U S A (2013) 1.97
Vaccinia virus gene D8 encodes a virion transmembrane protein. J Virol (1988) 1.78
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol (2007) 1.73
IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination. J Biol Chem (2007) 1.68
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog (2008) 1.57
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol (2002) 1.57
Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation. Virology (2001) 1.56
Regulation of NF-κB by ubiquitination and degradation of the IκBs. Immunol Rev (2012) 1.51
Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J Gen Virol (1999) 1.46
Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol (2013) 1.41
Deletion of 55 open reading frames from the termini of vaccinia virus. Virology (1991) 1.34
The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities. Biochem Pharmacol (2007) 1.32
A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammation. J Virol (2004) 1.26
Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara. J Gen Virol (2005) 1.24
Down regulation of gene expression by the vaccinia virus D10 protein. J Virol (1999) 1.23
Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog (2011) 1.22
Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses. J Virol (2007) 1.22
Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. J Gen Virol (2006) 1.14
How vaccinia virus has evolved to subvert the host immune response. J Struct Biol (2011) 1.11
Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proc Natl Acad Sci U S A (2009) 1.11
A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses. PLoS One (2011) 1.10
Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog (2013) 1.08
Viral interference with innate immunity by preventing NF-κB activity. Cell Microbiol (2011) 1.03
A238L inhibits NF-ATc2, NF-kappa B, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300. J Immunol (2008) 1.02
Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein. PLoS One (2012) 1.01
Structural basis for targeting of human RNA helicase DDX3 by poxvirus protein K7. Structure (2009) 1.01
Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence. PLoS Pathog (2011) 1.00
Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice. J Virol (2012) 0.98
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence. J Gen Virol (2012) 0.97
A nuclear inhibitor of NF-kappaB encoded by a poxvirus. J Virol (2010) 0.94
Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J Gen Virol (2013) 0.90
Crosstalk between the type 1 interferon and nuclear factor kappa B pathways confers resistance to a lethal virus infection. Cell Host Microbe (2013) 0.88
Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy. J Gen Virol (2013) 0.86
Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. J Gen Virol (2013) 0.86
Walleye dermal sarcoma virus rv-cyclin inhibits NF-kappaB-dependent transcription. Virology (2009) 0.84
A vaccinia virus deletion mutant reveals the presence of additional inhibitors of NF-kappaB. J Virol (2010) 0.80
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med (2003) 4.64
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 4.30
The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med (2003) 2.85
Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med (2005) 2.66
Poxvirus genomes: a phylogenetic analysis. J Gen Virol (2004) 2.40
Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science (2006) 1.84
Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus. EMBO J (2012) 1.75
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol (2007) 1.73
Vaccinia virus morphogenesis and dissemination. Trends Microbiol (2008) 1.73
Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J Gen Virol (2005) 1.70
Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination. Nat Med (2006) 1.64
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc Natl Acad Sci U S A (2006) 1.62
Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. J Gen Virol (2002) 1.59
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog (2008) 1.57
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol (2002) 1.57
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife (2012) 1.53
Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol (2005) 1.52
An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model. J Gen Virol (2005) 1.45
A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol (2003) 1.43
Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol (2013) 1.41
The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J Gen Virol (2002) 1.38
Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol (2002) 1.36
Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol (2003) 1.34
The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J Gen Virol (2002) 1.33
Vaccinia virus cores are transported on microtubules. J Gen Virol (2003) 1.33
A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. J Gen Virol (2002) 1.30
Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy. J Gen Virol (2006) 1.25
The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice. J Clin Invest (2010) 1.24
Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog (2011) 1.22
Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infection. J Exp Med (2003) 1.19
A new inhibitor of apoptosis from vaccinia virus and eukaryotes. PLoS Pathog (2007) 1.17
Identification of human and animal adenoviruses and polyomaviruses for determination of sources of fecal contamination in the environment. Appl Environ Microbiol (2006) 1.14
Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. J Gen Virol (2006) 1.14
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy. J Gen Virol (2005) 1.12
How vaccinia virus has evolved to subvert the host immune response. J Struct Biol (2011) 1.11
The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J Gen Virol (2002) 1.10
Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog (2013) 1.08
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A (2007) 1.08
The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model. J Gen Virol (2003) 1.07
Intradermal immune response after infection with Vaccinia virus. J Gen Virol (2006) 1.06
An investigation of incorporation of cellular antigens into vaccinia virus particles. J Gen Virol (2002) 1.05
Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog (2008) 1.04
Structure of CrmE, a virus-encoded tumour necrosis factor receptor. J Mol Biol (2007) 1.03
Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax. J Gen Virol (2008) 1.01
Inhibition of the RNA polymerase III-mediated dsDNA-sensing pathway of innate immunity by vaccinia virus protein E3. J Gen Virol (2010) 1.00
Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence. PLoS Pathog (2011) 1.00
Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist. J Biol Chem (2006) 0.99
The vaccinia virus soluble interferon-gamma receptor is a homodimer. J Gen Virol (2002) 0.99
Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. Virology (2002) 0.98
A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection. J Immunol (2003) 0.98
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence. J Gen Virol (2012) 0.97
Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB. J Biol Chem (2011) 0.97
Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion export. PLoS Pathog (2010) 0.97
Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein. J Gen Virol (2005) 0.95
Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus. Methods Mol Biol (2004) 0.94
Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence. J Gen Virol (2007) 0.93
B and CTL responses to the ALK protein in patients with ALK-positive ALCL. Int J Cancer (2006) 0.93
Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model. J Gen Virol (2006) 0.92
Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts. J Virol (2009) 0.90
Six-transmembrane topology for Golgi anti-apoptotic protein (GAAP) and Bax inhibitor 1 (BI-1) provides model for the transmembrane Bax inhibitor-containing motif (TMBIM) family. J Biol Chem (2012) 0.90
Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J Gen Virol (2013) 0.90
Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. J Gen Virol (2008) 0.89
Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response. J Gen Virol (2007) 0.89
Development of a quantitative PCR assay for the quantitation of bovine polyomavirus as a microbial source-tracking tool. J Virol Methods (2009) 0.89
Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane. J Gen Virol (2009) 0.88
A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog (2013) 0.88
Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes. J Immunol (2010) 0.87
Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails. J Gen Virol (2004) 0.86
A new member of the interleukin 10-related cytokine family encoded by a poxvirus. J Gen Virol (2004) 0.86
Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy. J Gen Virol (2013) 0.86
Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. J Gen Virol (2013) 0.86
Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection. J Gen Virol (2008) 0.86
Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface. J Gen Virol (2002) 0.85
The vaccinia virus B9R protein is a 6 kDa intracellular protein that is non-essential for virus replication and virulence. J Gen Virol (2002) 0.85
A mechanism for induction of a hypoxic response by vaccinia virus. Proc Natl Acad Sci U S A (2013) 0.84
hGAAP promotes cell adhesion and migration via the stimulation of store-operated Ca2+ entry and calpain 2. J Cell Biol (2013) 0.83
Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein. J Gen Virol (2010) 0.80
Mutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear factor kappaB activation. J Gen Virol (2010) 0.80
Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1. J Gen Virol (2003) 0.80
Human and viral Golgi anti-apoptotic proteins (GAAPs) oligomerize via different mechanisms and monomeric GAAP inhibits apoptosis and modulates calcium. J Biol Chem (2013) 0.79
Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions. J Gen Virol (2012) 0.78
Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue. J Gen Virol (2006) 0.77
Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor. Immunology (2015) 0.77
Serological responses in humans to the smallpox vaccine LC16m8. J Gen Virol (2011) 0.77
The African swine fever virus protein j4R binds to the alpha chain of nascent polypeptide-associated complex. J Virol (2002) 0.76
Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein. J Gen Virol (2012) 0.76
Notes on transient host range selection for engineering vaccinia virus strain MVA. Biotechniques (2002) 0.76
Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2. PLoS Pathog (2016) 0.75
Cost-effective method for microbial source tracking using specific human and animal viruses. J Vis Exp (2011) 0.75
[Rapid cell-to-cell spread: a story of jumping viruses]. Med Sci (Paris) (2010) 0.75